Trials / Recruiting
RecruitingNCT05991193
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
A Non-interventional Study and Its Clinical Relevance With Central Nervous System Metastatic Epidermal Growth Factor Receptor Mutation Positive Non-small Cell Lung Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Hunan Province Tumor Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Detailed description
This is a descriptive observational study, in which data are collected in an EGFR mutant NSCLC. Our research plan aims to use multi-omics approaches to predict the likelihood of patients developing brain metastases, assess the prognosis of brain metastasis treatment, and identify potential biomarkers.
Conditions
Timeline
- Start date
- 2023-12-29
- Primary completion
- 2025-08-30
- Completion
- 2025-12-31
- First posted
- 2023-08-14
- Last updated
- 2024-09-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05991193. Inclusion in this directory is not an endorsement.